心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

校正|2020 AHA科学声明：新型降糖药物对糖尿病和慢性肾病患者的心肾保护作用

2020-10-27 美国心脏协会 Circulation

部分信息校正。

中文标题：

校正|2020 AHA科学声明：新型降糖药物对糖尿病和慢性肾病患者的心肾保护作用

发布机构：

美国心脏协会

发布日期：

2020-10-27

简要介绍：

部分信息校正。

相关资料下载：
[AttachmentFileName(sort=1, fileName=10.1161@CIR.0000000000000935.pdf)] GetToolGuiderByIdResponse(projectId=1, id=ad47e1c00199ea77, title=校正|2020 AHA科学声明：新型降糖药物对糖尿病和慢性肾病患者的心肾保护作用, enTitle=, guiderFrom=Circulation, authorId=0, author=, summary=部分信息校正。, cover=https://img.medsci.cn/20201027/1603781455380_5385871.png, journalId=0, articlesId=null, associationId=60, associationName=美国心脏协会, associationIntro=美国心脏协会（AHA，American Heart Association）是心脏病学领域比较正要的学会之一，致力于心脏病和卒中的预防与治疗，提供相关继续教育、流行病学年度报告。每年举办学术年会报道中的的临床试验结果等，有官方杂志《美国心脏协会杂志》，提供心血管疾病和卒中相关的指南及专家共识，更新的比较快。, copyright=0, guiderPublishedTime=Tue Oct 27 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p>部分信息校正。</p>, tagList=[], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其它, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=0, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2413, appHits=156, showAppHits=0, pcHits=575, showPcHits=2257, likes=0, shares=10, comments=11, approvalStatus=1, publishedTime=Tue Oct 27 14:51:33 CST 2020, publishedTimeString=2020-10-27, pcVisible=1, appVisible=1, editorId=5385871, editor=Lexi, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=Lexi, createdTime=Tue Oct 27 14:51:29 CST 2020, updatedBy=5385871, updatedName=Lexi, updatedTime=Wed Jan 03 03:59:22 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=10.1161@CIR.0000000000000935.pdf)])
10.1161@CIR.0000000000000935.pdf
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1249383, encodeId=2122124938355, content=空白？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3cf8329898, createdName=ms4000000253391997, createdTime=Fri Sep 16 19:02:53 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920704, encodeId=4202920e042c, content=空白的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a25456478, createdName=ms9000001879619014, createdTime=Thu Jan 28 11:40:06 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901567, encodeId=a1fa90156eee, content=看不了？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/916441d2913648269ede0b8db11ab6c2/0a36cd040f95424b9d105ae671387d9a.jpg, createdBy=52415437799, createdName=百度人生, createdTime=Mon Nov 23 20:49:23 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896990, encodeId=230b896990f9, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200726/6c8062e399e6465bb80292cce602d8f4/b51d2afbf62b4f8aa3badda5c301da3e.jpg, createdBy=95dc2584303, createdName=lyw, createdTime=Thu Nov 05 00:29:06 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895571, encodeId=bd668955e131, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec1b5134851, createdName=146636e7m23暂无昵称, createdTime=Fri Oct 30 06:04:04 CST 2020, time=2020-10-30, status=1, ipAttribution=)]
    2022-09-16 ms4000000253391997

    空白？

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1249383, encodeId=2122124938355, content=空白？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3cf8329898, createdName=ms4000000253391997, createdTime=Fri Sep 16 19:02:53 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920704, encodeId=4202920e042c, content=空白的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a25456478, createdName=ms9000001879619014, createdTime=Thu Jan 28 11:40:06 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901567, encodeId=a1fa90156eee, content=看不了？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/916441d2913648269ede0b8db11ab6c2/0a36cd040f95424b9d105ae671387d9a.jpg, createdBy=52415437799, createdName=百度人生, createdTime=Mon Nov 23 20:49:23 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896990, encodeId=230b896990f9, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200726/6c8062e399e6465bb80292cce602d8f4/b51d2afbf62b4f8aa3badda5c301da3e.jpg, createdBy=95dc2584303, createdName=lyw, createdTime=Thu Nov 05 00:29:06 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895571, encodeId=bd668955e131, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec1b5134851, createdName=146636e7m23暂无昵称, createdTime=Fri Oct 30 06:04:04 CST 2020, time=2020-10-30, status=1, ipAttribution=)]
    2021-01-28 ms9000001879619014

    空白的

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1249383, encodeId=2122124938355, content=空白？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3cf8329898, createdName=ms4000000253391997, createdTime=Fri Sep 16 19:02:53 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920704, encodeId=4202920e042c, content=空白的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a25456478, createdName=ms9000001879619014, createdTime=Thu Jan 28 11:40:06 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901567, encodeId=a1fa90156eee, content=看不了？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/916441d2913648269ede0b8db11ab6c2/0a36cd040f95424b9d105ae671387d9a.jpg, createdBy=52415437799, createdName=百度人生, createdTime=Mon Nov 23 20:49:23 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896990, encodeId=230b896990f9, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200726/6c8062e399e6465bb80292cce602d8f4/b51d2afbf62b4f8aa3badda5c301da3e.jpg, createdBy=95dc2584303, createdName=lyw, createdTime=Thu Nov 05 00:29:06 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895571, encodeId=bd668955e131, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec1b5134851, createdName=146636e7m23暂无昵称, createdTime=Fri Oct 30 06:04:04 CST 2020, time=2020-10-30, status=1, ipAttribution=)]
    2020-11-23 百度人生

    看不了？

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1249383, encodeId=2122124938355, content=空白？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3cf8329898, createdName=ms4000000253391997, createdTime=Fri Sep 16 19:02:53 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920704, encodeId=4202920e042c, content=空白的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a25456478, createdName=ms9000001879619014, createdTime=Thu Jan 28 11:40:06 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901567, encodeId=a1fa90156eee, content=看不了？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/916441d2913648269ede0b8db11ab6c2/0a36cd040f95424b9d105ae671387d9a.jpg, createdBy=52415437799, createdName=百度人生, createdTime=Mon Nov 23 20:49:23 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896990, encodeId=230b896990f9, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200726/6c8062e399e6465bb80292cce602d8f4/b51d2afbf62b4f8aa3badda5c301da3e.jpg, createdBy=95dc2584303, createdName=lyw, createdTime=Thu Nov 05 00:29:06 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895571, encodeId=bd668955e131, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec1b5134851, createdName=146636e7m23暂无昵称, createdTime=Fri Oct 30 06:04:04 CST 2020, time=2020-10-30, status=1, ipAttribution=)]
    2020-11-05 lyw

    看看

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1249383, encodeId=2122124938355, content=空白？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3cf8329898, createdName=ms4000000253391997, createdTime=Fri Sep 16 19:02:53 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920704, encodeId=4202920e042c, content=空白的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a25456478, createdName=ms9000001879619014, createdTime=Thu Jan 28 11:40:06 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901567, encodeId=a1fa90156eee, content=看不了？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/916441d2913648269ede0b8db11ab6c2/0a36cd040f95424b9d105ae671387d9a.jpg, createdBy=52415437799, createdName=百度人生, createdTime=Mon Nov 23 20:49:23 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896990, encodeId=230b896990f9, content=看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200726/6c8062e399e6465bb80292cce602d8f4/b51d2afbf62b4f8aa3badda5c301da3e.jpg, createdBy=95dc2584303, createdName=lyw, createdTime=Thu Nov 05 00:29:06 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895571, encodeId=bd668955e131, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec1b5134851, createdName=146636e7m23暂无昵称, createdTime=Fri Oct 30 06:04:04 CST 2020, time=2020-10-30, status=1, ipAttribution=)]
    2020-10-30 146636e7m23暂无昵称

    好好

    0